Home pageDEVA • IST
add
Deva Holding AS
Chiusura precedente
64,35 ₺
Intervallo giornaliero
64,50 ₺ - 66,65 ₺
Intervallo annuale
51,00 ₺ - 81,75 ₺
Cap di mercato
13,28 Mld TRY
Volume medio
969,51K
Rapporto P/E
40,10
Dividendo/Prezzo
-
Borsa valori principale
IST
Notizie del mercato finanziario
Dati finanziari
Conto economico
Entrate
Utile netto
| (TRY) | set 2025info | Variazione Y/Y |
|---|---|---|
Entrate | 4,47 Mld | -8,27% |
Spese di gestione | 1,55 Mld | 29,60% |
Utile netto | -20,81 Mln | 94,15% |
Margine di profitto netto | -0,47 | 93,55% |
Utili per azione | — | — |
EBITDA | 237,92 Mln | -77,02% |
Aliquota fiscale effettiva | 84,84% | — |
Stato patrimoniale
Totale attivo
Totale passivo
| (TRY) | set 2025info | Variazione Y/Y |
|---|---|---|
Investimenti cash/breve termine | 2,49 Mld | -12,84% |
Totale attivo | 35,50 Mld | 22,79% |
Totale passivo | 9,02 Mld | -1,21% |
Patrimonio netto totale | 26,48 Mld | — |
Azioni in circolazione | 200,02 Mln | — |
Prezzo/valore contabile | 0,49 | — |
Rendimento delle attività | -0,75% | — |
Rendimento sul capitale | -0,83% | — |
Flusso di cassa
Flusso di cassa netto
| (TRY) | set 2025info | Variazione Y/Y |
|---|---|---|
Utile netto | -20,81 Mln | 94,15% |
Liquidità di esercizio | 1,53 Mld | -32,16% |
Liquidità da investimenti | -517,27 Mln | 61,38% |
Liquidità da finanziamenti | -750,38 Mln | -25,01% |
Flusso di cassa netto | 243,03 Mln | 53,78% |
Flusso di cassa libero | -620,67 Mln | 22,50% |
Informazioni
DEVA Holding A.Ş. is a leading Turkish pharmaceutical company founded in 1958. As of 2024, it ranked 3rd in unit sales and 6th in TL sales in Turkey’s pharmaceutical market.
The company operates three EU GMP- and US FDA-approved facilities in Çerkezköy and Kartepe, with an annual production capacity of 620 million units. DEVA’s portfolio covers 10 therapeutic areas, including cardiovascular, dermatology, ophthalmology, hematology, and anti-infectives, and includes 1,404 registered products across 82 countries.
Recognized as Turkey’s top pharmaceutical company in R&D spending by Turkishtime’s 2024 R&D 250 Report, DEVA employs over 500 researchers and 3,000 staff in total. Guided by sustainability and innovation, the company focuses on developing accessible, effective, and environmentally responsible healthcare solutions for both domestic and global markets. Wikipedia
Fondazione
22 set 1958
Sito web
Dipendenti
3.036
